Carlsmed, Inc. (CARL): Gross Profit

Annual figures by period end, from SEC filings.

$38.04M
Year ended 2025-12-31
$48.50M
Trailing 12 months to 2026-06-30
2024-12-31: $20.05M2025-12-31: $38.04M$38.04M
2024-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$38.04M+89.7%2026-02-25, From 2025-01-01
2024-12-31$20.05Mn/a2026-02-25, From 2024-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Carlsmed, Inc. (CARL)2025-12-31$38.04M+89.7%
Apyx Medical Corp (APYX)2025-12-31$33.04M+12.5%
Shoulder Innovations, Inc. (SI)2025-12-31$36.20M+48.7%
TriSalus Life Sciences, Inc. (TLSI)2025-12-31$38.19M+50.8%
CVRx, Inc. (CVRX)2025-12-31$48.34M+12.5%
SANUWAVE Health, Inc. (SNWV)2025-12-31$33.97M+38.4%
LENSAR, Inc. (LNSR)2025-12-31$27.12M+4.9%
SS Innovations International, Inc. (SSII)2025-12-31$19.54M+131.2%
Meihua International Medical Technologies Co., Ltd. (MHUAF)2025-12-31$19.16M-42.5%

Compare CARL, APYX, SI, TLSI side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗